New Standards of Practice - Prescribing Benzodiazepines & Z-Drugs and Authorizing Cannabis

Standard of Practice for Prescribing Benzodiazepines and Z-Drugs

THIS STANDARD IS EFFECTIVE NOVEMBER 1, 2020.

This Standard establishes the standard of practice and ethical requirements of all members in relation to prescribing benzodiazepines and/or Z-Drugs for maximum safety for all patients whether in the community or in a health care facility. 

To assist members in their prescribing practices CPSM has created two documents:

  • Standard which establishes the compulsory rules for prescribing benzodiazepines and Z-Drugs
  • Contextual Information and Resources document which explains the risks in Manitoba, for elderly patients, and in general (be mindful of polypharmacy), impairment for driving, and suggested resources.

 

 

Standard of Practice for Authorizing Cannabis for Medical Purposes

THIS STANDARD IS EFFECTIVE NOVEMBER 1, 2020

This Standard articulates the standard of practice and ethical requirements for all members using their clinical skill, knowledge, and judgment in authorizing cannabis for medical purposes. 

To assist members in their prescribing practices CPSM has created two documents:

  • Standard which establishes the compulsory rules for authorizing cannabis and
  • Contextual Information and Resources document which explains the legal framework, available evidence for clinical recommendations, dosages, the medical authorization document, fees, and suggested resources.